Quality assurance in renography a review

Nuclear Medicine Communications

Volumn 19, Issue 7, 1998, Pages 711-716

  Cosgriff, P S ^a  

^a PILGRIM HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PENTETATE TECHNETIUM TC 99M; SUCCIMER;

DIAGNOSTIC ACCURACY; KIDNEY SCINTISCANNING; PATIENT SELECTION; RENOGRAPHY; REVIEW; STANDARDIZATION;

EID: 0031870328     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199807000-00014     Document Type: Article

References (50)

1. Woolfson RG, Neild GH. The true clinical significance of renography in nephrourology. Eur J Nucl Med 1997; 24: 557-570.
2. Albala DM, Richardson JR Jr, Heaney JA. Diuretic renal scan: Is it always reliable? J Endourol 1994; 8: 405-410.
3. Ramsay D, Belton I, Finlay D. A review of captopril renal scintigraphy and its effect on patient management. Nucl Med Commun 1997; 18: 631-633.
4. O’Reilly P, Aurell M, Britton K, Kletter K, Rosenthal L, Testa T. Consensus on diuresis renography for investigating the dilated upper urinary tract. J Nucl Med 1996; 37: 1872-1876.
5. Taylor A, Nally J, Aurell M et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. J Nucl Med 1996; 37: 1876-1882.
6. Cosgriff PS, Lawson RS, Nimmon CC. Towards standardization in gamma camera renography. Nucl Med Commun 1992; 13: 586-585.
7. Conway JJ. ’Well-tempered’ diuresis renography: Its historical development, physiological and technical pitfalls, and standardized technique protocol. Sem Nucl Med 1992; 22: 74-84.
8. Blaufox MD. Captopril renography: Considerations in the selection of radiopharmaceutical, provocative agents and hypertensive patients. Am J Hypertens 1991; 4: 675S-677S.
9. Nally IV, Chen C, Fine E et al. Diagnostic criteria of renovascular hypertension with captopril renography. Am J Hypertens 1991; 4: 749S-752S
10. Blaufox MD, Aurell M, Bubeck B et al. Report of the radionuclides in Nephrourology Committee on renal clearance. J Nucl Med 1997; 37: 1883-1890.
11. Delamothe T. Wanted: Guidelines that doctors will follow. Br Med J 1993; 307: 218.
12. Forbes E, Clarke SEM, Buxton-Thomas M et al. The development of regional nuclear medicine audit in South Thames. Nucl Med Commun 1997; 18: 693-697.
13. Todd-Pokropek A, Cradduck TD, Deconinck F. A file format for the exchange of nuclear medicine image data: A specification of Interfile version 3.3. Nucl Med Commun 1992; 13: 673-699.
14. COST B2 Final Report (EUR 17916 EN): Quality assurance of nuclear medicine software (Cosgriff PS, ed.). Luxembourg: Office for Official Publications of the European Communities, 1997.
15. Fleming JS, Cosgriff P, Houston A, larritt P, Skrypniuk J, Whalley D. UK audit of relative renal function assessment by DMSA scintigraphy (abstract). Nucl Med Commun 1998; 19: 376.
16. Samal M, Bergmann H. Hybrid phantoms for testing the measurement of regional dynamics in dynamic renal scintigraphy. Nucl Med Commun 1998; 19: 161-171.
17. O’Reilly PH. Nuclear medicine in urology. Contrib Nephrol 1987; 56: 215-224.
18. O’Reilly PH, Lawson RS, Shields RA et al. The dilated nonobstructed renal pelvis. Br J Urol 1981; 53: 205-210.
19. Kletter K, Nürnberger N. Diagnostic potential of diuresis renography: Limitations by severity of hydronephrosis and by impairment of renal function. Nucl Med Commun 1989; 10: 51-61.
20. English PJ, Testa HJ, Shields RA et al. Modified method of diuresis renography for the assessment of equivocal pel-viureteric junction obstruction. Br J Urol 1987; 59: 10-14.
21. Nimmon CC, Britton KE, Bomanji J et al. Quantitation of the frusemide response, with a comparison with parenchymal transit time analysis in the 99Tcm DTPA renal study. In: Schmidt HAE, Csernay L, eds. Nuklearmedizin. Stuttgart: Schattauer, 1988: 472-475.
22. Upsdell SM, Testa HJ, Lawson RS, Carroll RNP, Edwards EC. The uses and interpretation of modified diuresis renography. Contrib Nephrol 1990; 79: 103-107.
23. Chaiwatanarat T, Padhy, Bomanji B et al. Validation of renal output efficiency as an objectice quantitative parameter in the evaluation of upper urinary tract obstruction. J Nucl Med 1993; 34: 845-848.
24. Saunders AB, Choong KKL, Larcos G, Farlow D, Gruenewald SM. Assessment of pediatric hydronephrosis using output efficiency. J Nucl Med 1997; 38: 1483-1486.
25. Jones DA, Lupton EW, George NJR. Effect of bladder filling on upper tract urodynamics in man. Br J Urol 1990; 65: 492-496.
26. Jamar F, Piret L, Wese F-X, Beckers C. Influence of ureteral status on kidney washout during technetium-99m-DTPA diuresis renography in children. J Nucl Med 1992; 33: 73-78.
27. Herrin JT. Effects of ureteral function on assessment of hydronephrosis. J Nucl Med 1992; 33: 78-80.
28. Gordon I. Assessment of pediatric hydronephrosis using output efficiency. J Nucl Med 1997; 38: 1487-1489.
29. Gordon I, Mialdea Fernandez RM, Peters AM. Pelvi-ureteric junction obstruction: The value of a postmicturition view in 99Tcm-DTPA diuretic renography. Br J Urol 1988; 61: 409-412.
30. Upsdell SM, Leeson SM, Brooman PJC, O’Reilly PH. Diuretic-induced urinary flow rates at varying clearances and their relevance to the performance and interpretation of diuresis.renography. Br J Urol 1988; 61: 14-18.
31. Eising EG, Bonzel KE, Zander C, Farahati J, Reiners C. Value of diuresis renography in the post-natal period of assumed physiological renal immaturity. Nucl Med Commun 1997; 18: 1008-1016.
32. Platt JF. Urinary obstruction. In: Dunnock NR, ed. The radiological clinics of North America: Advances in uror-adiology II. Philadelphiam, PA: WB Saunders, 1996: 1113-1129.
33. Gordon I. Urinary tract infection in paediatrics: The role of diagnostic imaging. Br J Radiol 1990; 63: 507-511.
34. O’Reilly PH. Diuresis renography 8 years later: An update. J Urol 1986; 136: 993-996.
35. Hoff SA, McDowell GC, Byard M. Diuretic radionuclide assessment of obstruction in the infant: Guidelines for successful interpretation. J Urol 1988; 140: 1167-1168.
36. Wong JCH, Rossleigh MA, Farnsworth RH. Utility of tech-netium-99m-MAG3 diuretic renography in the neonatal period. J Nucl Med 1995; 36: 2214-2219.
37. Prigent A. The diagnosis of renovascular hypertension: The role of captopril renal scintigraphy and related issues. Eur J Nucl Med 1993; 20: 625-644
38. Brawn LA, Ramsay LE. Is ’improvement’ real with percutaneous transluminal angiopasty in the management of renovascular hypertension. Lancet 1987; 2: 1313-1316.
39. Dondi M, Fanti S, De Fabritiis A et al. Prognostic value of captoptil renal scintigraphy in renovacular hypertension. J Nucl Med 1992; 33: 2040-2044.
40. Simon N, Franklin SS, Bleifer KH, Morton MH. Clinical characteristics of renovascular hypertension. JAMA 1972; 220: 1209-1218.
41. Ramsey LE, Waller PC. Blood pressure response to percutaneous transluminal angiopasty for renovascular hypertension: An overview of published series. Br Med J 1990; 300: 569-572.
42. Schreij G, van Kroonenburgh MJ, Heidendal GK, van der Pol HA, de Leeuw PW. Interpretation of captopril renography by nuclear medicine physicians. J Nucl Med 1995; 36: 2192-2195.
43. Gordon I. Indirect radionuclide cystography-the coming of age. Nucl Med Commun 1989; 10: 457-458.
44. Hilson AJW. The renal transplant perfusion index: Where are we now? Eur J Nucl Med 1991; 18: 227-228.
45. Britton KE, Nimmon CC, Whitfield HN et al. The evaluation of obstructive nephropathy by means of parenchymal retention functions. In: Hollenberg NK, Lange S, eds. Radionuclides in nephrology. Stuttgart: Georg Thieme, 1980: 164-172.
46. Munoz A, Puchal R, Castelao AM et al. Renogram deconvolution in the management of diabetic nephropathy: Utility of the measurement of initial tracer uptake. Nucl Med Commun 1997; 18: 1029-1035.
47. Ilgin N, Iftehar SA, Vural G, Bozkirli I, Gokcora N. Evaluation of renal function following treatment with extracor-poreal shock wave lithotripsy (ESWL): The use of whole-kidney, parenchymal and pelvic transit times. Nucl Med Commun 1998; 19: 155-159.
48. Mackenzie JF. DMSA-the new ’gold standard’. Nucl Med Commun 1990; 11: 725-726.
49. Freeman LM. The radionuclide renal scan: Past, present and future. Contrib Nephrol 1990; 79: 87-98.
50. Itoh K, Kato C, Shiga T. Expressing kidney uptake during 99Tcm-MAG3 renography in terms of administered activity. Nucl Med Commun 1995; 16: 504-508.